Skip First Level Navigation | Skip All Navigation
![]() |
| Maine CDC Home | Contact Us |
MAINE CDC INFORMATION
District Public HealthINFO FOR HEALTH PROVIDERS
|
MeCDC Home > Press Releases > Press Release
Maine CDC Press ReleaseOctober 1, 2009 H1N1 Vaccine Will Arrive Next WeekFOR MORE INFORMATION, PLEASE CONTACT: Initial distribution focuses on young children Dr. Dora Anne Mills said that she expects about 13,000 doses of the H1NI Live Attenuated Intranasal Vaccine to be included in these initial shipments. This vaccine, which is a nasal spray, is licensed for healthy people ages 2-49 who are not pregnant. "In terms of the high-priority populations for H1N1, this vaccine is most appropriate for young healthy children and those who are frequently in contact with young infants," Mills said. "We are urging pediatric and obstetrical health care providers to register and submit orders for H1N1 vaccine as soon as possible." These initial doses will be distributed primarily to pediatric health care providers and will be focused on children between age two and four and those who are healthy and under 50 who live in a house with an infant under age 6 months or provide care to an infant. The U.S. CDC also shared a timeline for all of the H1N1 vaccine types, including the nasal spray, multi-dose vials and single-dose vials. This will help guide the ordering and distribution process, said Mills. "Each formulation has different parameters for use," she said. "We are developing a distribution plan based on both the availability of the vaccine and the priority groups we are trying to reach. These include pregnant women, household contacts of young infants, children, young adults, health care workers and adults under age 65 with underlying health conditions. We know communities need this information to start planning and it’s our hope to have a distribution plan completed this week." The Maine CDC offers these reminders to mitigate the effects of H1N1:
For more information, visit: http://www.maineflu.gov |
| Copyright © 2008 All rights reserved. |